Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05932745 · ClinicalTrials.gov registry record · NA

Effects of Novel E-cigarette Constituents on Adults TCORS 3.0

A NA study of Nicotine Use Disorder, sponsored by Yale University.

Recruiting
Registry status
NA
Development phase
66
Enrollment target
1
Study location

NCT05932745 is a NA study of Nicotine Use Disorder that is actively recruiting participants, run by Yale University. The registered enrollment target is 66 participants, below the 94-participant average among 7 other Nicotine Use Disorder trials with a reported enrollment target (30% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05932745, a NA study of Nicotine Use Disorder, is actively recruiting participants, sponsored by Yale University.

RECRUITING
Registry status
NA
Development phase
66 participants
Enrollment target
1
Study location

Study Summary

This study is an examination of the influence of cooling components of WS-3, WS-23, and menthol on the appeal and addiction potential of nicotine-containing e-liquids among adults.

Conditions Studied

Nicotine Use Disorder

Interventions

  • OTHER E-liquid coolant (No WS-3) for non-menthol (1)
  • OTHER E-liquid coolant (No WS-3) for low (0.1%) menthol (1)
  • OTHER E-liquid coolant (No WS-3) for high (2.0%) menthol (1)
  • OTHER E-liquid coolant (Low [0.1%] WS-3) for non-menthol (2)
  • OTHER E-liquid coolant (Low [0.1%] WS-3) for low (0.1%) menthol (2)

Study Locations (1)

Connecticut

  • JB Pierce Lab - New Haven

Trial Details

FieldValue
Enrollment Target 66 participants
Start Date 2025-06-20
Est. Completion 2026-05
Phase NA

Sponsor

Yale University

1,492 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05932745

The ClinicalTrials.gov registry entry for NCT05932745 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 66 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 94-participant average among 7 other Nicotine Use Disorder trials with a reported enrollment target (30% lower). The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Nicotine Use Disorder appearing as the primary indexed condition, and to 5 interventions - of which E-liquid coolant (No WS-3) for non-menthol (1) is the first listed.

NCT05932745 reports 1 study location spanning 1 distinct geographic area - top geographies include Connecticut.

Frequently Asked Questions

What is clinical trial NCT05932745 about?

NCT05932745 is a clinical study titled "Effects of Novel E-cigarette Constituents on Adults TCORS 3.0". This study is an examination of the influence of cooling components of WS-3, WS-23, and menthol on the appeal and addiction potential of nicotine-containing e-liquids among adults.

What is the current status of trial NCT05932745?

This trial is currently recruiting. It is a NA study. The enrollment target is 66 participants. The study started on 2025-06-20. Estimated completion is 2026-05.

What conditions does trial NCT05932745 study?

This clinical trial studies the following conditions: Nicotine Use Disorder.

What interventions are being tested in trial NCT05932745?

The interventions under investigation include: E-liquid coolant (No WS-3) for non-menthol (1) (OTHER), E-liquid coolant (No WS-3) for low (0.1%) menthol (1) (OTHER), E-liquid coolant (No WS-3) for high (2.0%) menthol (1) (OTHER), E-liquid coolant (Low [0.1%] WS-3) for non-menthol (2) (OTHER), E-liquid coolant (Low [0.1%] WS-3) for low (0.1%) menthol (2) (OTHER).

Who is sponsoring clinical trial NCT05932745?

This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05932745 being conducted?

This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Nicotine Use Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Nicotine Use Disorder

All registered trials for this condition

Connecticut

All trials with a study site in Connecticut

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.